Health Care Reform Update - February 20, 2011

On February 14th a conservative activist group with support from Tea Party sympathizers and led by former House Majority Leader Dick Armey (R-TX) sent a letter to GOP leaders in the House insisting that Republicans should refuse to “reward collaborators” by not helping industry groups that ultimately endorsed passage of the Affordable Care Act (ACA) in any of their legislative priorities. The memo also outlines a repeal strategy with seven key points. A copy of the memo can be found here.

In a letter released on February 14th, a group of eight Democratic Senators wrote leaders at the Department of Justice and the Federal Trade Commission to encourage them to coordinate anti-trust issues that may arise under the ACA’s accountable care organizations (ACOs). The letter was signed by Sens. Mark Udall (D-CO), Jeanne Shaheen (D-NH), Tom Udall (D-NM), Mark Warner (D-VA), Michael Bennet (D-CO), Jeff Merkley (D-OR), Kay Hagan (D-NC), and Ron Wyden (D-OR).

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz Levin - Health Law & Policy Matters | Attorney Advertising

Written by:


Mintz Levin - Health Law & Policy Matters on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.